deltatrials
Active Not Recruiting PHASE1/PHASE2 INTERVENTIONAL 5-arm NCT06334432

Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

A Phase 1/2, First-in-Human, Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

Sponsor: Nuvation Bio Inc.

Conditions Advanced Solid Tumor HER2-negative Breast Cancer Metastatic Castration-resistant Prostate Cancer (mCRPC) Pancreatic Cancer Platinum-resistant Ovarian Cancer (PROC)
Interventions NUV-1511
Updated 5 times since 2024 Last updated: Jan 12, 2026 Started: Mar 14, 2024 Primary completion: Mar 31, 2027 Completion: Oct 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Advanced Solid Tumor and HER2-negative Breast Cancer, this trial is ongoing. The trial is conducted by Nuvation Bio Inc. and has accumulated 5 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Feb 2026 · 16 months · monthly snapshotRecruiting~Feb 2026 – present · 4 months · monthly snapshotActive Not Recruiting

Change History

5 versions recorded

  1. Feb 2026 — Present [monthly]

    Active Not Recruiting PHASE1/PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Oct 2024 — Feb 2026 [monthly]

    Recruiting PHASE1/PHASE2

  3. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE1/PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  5. Apr 2024 — Jul 2024 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Mar 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Nuvation Bio Inc.
Data source: Nuvation Bio Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations